Status:
NOT_YET_RECRUITING
Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery
Lead Sponsor:
Lebanese American University
Conditions:
Pain
Pain Management Following Cardiopulmonary Bypass Surgery
Eligibility:
All Genders
25-80 years
Phase:
PHASE4
Brief Summary
Coronary artery bypass surgery (CABG), typically performed through a median sternotomy, causes significant postoperative pain. Managing this pain effectively while reducing reliance on opioids is esse...
Eligibility Criteria
Inclusion
- Age range: 25 - 80 years old
- Planned for elective OFF PUMP CABG
- Cognitively not impaired
- American Society of Anesthesiologists class 3
- Left ventricular ejection fraction ≥40%
- Consent form for the study signed
- No infection at the site of injection
- No contraindication for ESP block (thrombocytopenia, anticoagulation therapy)
- No documented allergy to ropivacaine or dexmedetomidine
Exclusion
- Refusal to participate in the study
- Emergency surgery
- American Society of Anesthesiologists class \>3
- Left ventricular ejection fraction \<40%
- Infection at the site of injection for ultrasound-guided ESPB
- Coagulation disorders
- Documented allergy to ropivacaine or dexmedetomidine
- Greater than first-degree heart block
- Bradycardia (heart rate \[HR\] \< 50 bpm)
- Pregnancy
- BMI ≥40
- Psychiatric illnesses that would interfere with the assessment of pain scores
- History of alcohol or drug abuse and chronic analgesic use
Key Trial Info
Start Date :
May 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 16 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06981949
Start Date
May 15 2025
End Date
May 16 2026
Last Update
May 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.